Portfolio (Quarterly)
Guide ↗
ANDERA PARTNERS
· CIK 0001757283| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KMTS | KESTRA MED TECHNOLOGIES LTD | Healthcare | 2,540,106.0 | $67.4M | 38.14% | NEW | — | $26.52 | -17.6% |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 1,591,917.0 | $57.8M | 32.71% | NEW | — | $36.29 | -17.5% |
| 3 | EVMN | EVOMMUNE INC | Healthcare | 1,897,362.0 | $32.5M | 18.39% | NEW | — | $17.12 | +35.6% |
| 4 | ABVX | ABIVAX SA | Healthcare | 78,125.0 | $10.5M | 5.97% | NEW | — | $134.86 | -7.6% |
| 5 | IVA | INVENTIVA SA | Healthcare | 1,818,181.0 | $8.5M | 4.79% | NEW | — | $4.65 | +10.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%